Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021

Background and Objectives: Patients with schizophrenia are often exposed to polypharmacotherapy, which may lead to drug—drug interactions. The aim of the study was to investigate the prevalence of potential drug—drug interactions (pDDIs) in hospitalized patients with schizophrenia spectrum disorders...

Descripción completa

Detalles Bibliográficos
Autores principales: Bačar Bole, Cvetka, Nagode, Katja, Pišlar, Mitja, Mrhar, Aleš, Grabnar, Iztok, Vovk, Tomaž
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962414/
https://www.ncbi.nlm.nih.gov/pubmed/36837485
http://dx.doi.org/10.3390/medicina59020284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962414/
https://www.ncbi.nlm.nih.gov/pubmed/36837485
http://dx.doi.org/10.3390/medicina59020284

Ejemplares similares